# Inbody Co., Ltd.

- Location (FDA's records): Seoul, KR
- FDA decisions: 4 (2020–2023): 4 510(k) clearances
- Product codes: DXN (4)
- 510(k) review time since 2016: median 198 days, against 186 for FDA's reviews in the same codes and years (2 of 4 faster)
- Predicates its devices cite: 4 (1 its own); citations of its devices by later devices: 2 (1 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Biospace Corporation Limited: 2 (https://510kreport.com/company/biospace)
- A&D Engineering, Inc.: 1 (https://510kreport.com/company/a-d-engineering)

## Firms that cite its devices most
- Korot Co., Ltd.: 1 (https://510kreport.com/company/korot)

## Its most-cited devices
- K200442: InBody (2020), cited by 1
- K221764: InBody Blood pressure monitor, Model BPBIO480KV (2022), cited by 1

## Recent decisions
- K231174: BPBIO750 (Aug 2, 2023)
- K221764: InBody Blood pressure monitor, Model BPBIO480KV (Oct 7, 2022)
- K200560: InBody (Jan 6, 2021)
- K200442: InBody (Dec 4, 2020)

Source page: https://510kreport.com/company/inbody